World

UK health agency warns of rising meningitis threat among young people

Nov 01, 2025

London [UK], November 1: Children and young adults, particularly university students, face an increased risk of meningococcal meningitis and septicaemia, the UK Health Security Agency (UKHSA) warned on Thursday, following a nationwide rise in confirmed cases.
UKHSA figures show 378 cases of invasive meningococcal disease (IMD) were recorded in 2024-25, up from 340 the previous year. Most infections involved children and young adults, with the MenB strain responsible for 90 percent of cases in babies and all cases among 15-to-19-year-olds.
Health officials cautioned that students starting university are especially vulnerable due to close contact and communal living. Declining vaccination rates among infants and teenagers have further heightened the risk.
"These latest figures are a stark reminder meningitis remains a serious threat to children and young adults," said Public Health Minister Ashley Dalton, urging eligible individuals to get vaccinated. She added that prompt immunization "offers crucial protection against this devastating disease, which can take hold in a matter of hours."
Symptoms include high fever, vomiting, muscle pain, headache, stiff neck, sensitivity to light, and a rash. Authorities stressed that vaccination remains the most effective defense against severe illness and death.
Source: Xinhua

More news

YuVerse Launches Instant-Build Voice & Video AI Platforms for Enterprises

Mumbai (Maharashtra) [India], August 27: YuVerse (a Yubi Group Company) has announced the launch of four new products at Yunite, its flagship event, held at Taj Santacruz, Mumbai. The launches span AI agent building, AI video generation, voice quality assurance and customer engagement campaign management, marking one of YuVerse's largest product releases to date. The event also featured a panel discussion on what it takes to move AI from pilots to enterprise scale, with leaders from Federal Bank, DBS Bank, CRIF and Lithion Power.

Aug 27, 2026